_阿托伐他汀的临床应用进展_阿托伐他汀的临床应用进展

《_阿托伐他汀的临床应用进展_阿托伐他汀的临床应用进展》由会员上传分享，免费在线阅读，更多相关内容在工程资料-天天文库。

1、diomyopathy[J]JAmCollCardioL2005.45(刀:969-981[5]YoshikawaT・BabaA・NagatomoYAutoimmunemechanismsunderlyingdilat-edcardiomyopathy[J]CircJ,2009,73(4):602-607[6]GroenewegenWA,WildeAALetterregardingarticlebyMcNairetal.*SCN5Amutationassociatedwithdilatedcardiomyopathconductiondisorder,andarrhythmia”[J]Cir

2、culation.2005.112(1):e9-10[7]GeJ»SunA,PaajanenV,etalMolecularandclinicalcharacterizationofanovelSCN5Amutationassociatedwithatrioventricularblockanddilatedcardio-myopathy[J]JCircArrhythmElectrophysioL2008.1(2):83-92[8]HesseM,KondoCS.ClarkRB・etalDilatedcardiomyopathyisassociatedwithreducedexpressiono

3、fthecardiacsodiumchannelScn5a[J]JCardiovascRes,2007,75(3):498-509「9]XuL・SunAJ・GeJBThecardiacsodiumchannelgeneSCN5Amutationanddilatedcardiomyopathy[J」JShengLiKeXueJinZhan(Chinese).2010.41(1):72-7410]WildeAA,BezzinaCRGeneticsofcardiacarrhythmiasTJ1Heart,2005.91:1352-1358[11]DarbarD・KannankerilPJ,Dona

4、hueBS,etalCardiacsodiumchannel(SCN5A)variantsassociatedwithatrialfibrillation[J]Circulation.2008,117:1927-1935(J2」McNairWP.KuL,TaylorMR・etalSCN5Amutationassociatedwithdilatedcardiomyopathy,conductiondisorder,andarrhythmia1JJCirculation.2004・110(15):2163-2167[13]OlsonTM.MichelsW,BallewJD>etalSodium

5、channelmutationsandsus-ceptibilitytoheartfailureandatrialfibrillation[J]JAMA•2005,293:447-454[14]FrustaciA・PrioriSG・PieroniM・etalCardiachistologicalsubstrateinpa-tientswithclinicalphenotypeofBrugadasyndromeIJ]Circulation.2005,112(24):3680-3687「i2+[15JWagnerS,DybkovaN,RasenackEC,etalCa/calmodulin-de

6、pendentproteinkinaseregulatescardiacNachannels[J]JClinInvest.2006,116(12):3127-3138[161BezzinaCR・RemmeCADilatedcardiomyopathyduetosodiumchanneldys-function：whatistheconnectionLJJ?CircArrhythmElectrophysiol»2008.1(2):80-82[17」舉玉华扩张型心肌病与钙通道阴滞剂的心肌保护作用[J〕心血管病学进展，1994・2:68-7024-「18]BeuckelmannDJ.Erdmann

7、ECa{2+)・currentsandintracellular[Ca1i-transientsinsingleventricularmyocytesisolatedfromterminallyfailinghumanmyocardium[JJBasicResCardiol・1992.87(suppl1):235-243[19]HoshijimaM・KnIIR・PashmforoushM・etalRevers